Sep. 30 at 10:55 AM
$QURE unless Matt Kapusta fcuks it up, like he did with Hema B to CSL Behring . In 2020 !!!
Now manufacturing that drug , under the agreement , the royalties received on sales , don’t cover the cost of the manufacturing process !!!
Real bright ex stock broker ..haha
Maybe the board will sell, and rid themselves of him and his using QURE as his own private ATM.
Yet, given the nationality of the company, its location , Netherlands, the Dutch never sell. Look at
$NXPI , had buyout offers ,in 2017 , and never sold !! QCOM tried twice .
As to a buyout price , 200 is rich. 175 would be a PT @Jjop9
